What is TARA stock price today?

TARA (Protara Therapeutics Inc) stock is trading at $5.44 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is TARA stock going up or down today?

TARA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy TARA stock now?

The decision to buy TARA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is TARA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for TARA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is TARA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if TARA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is TARA's P/E ratio?

P/E ratio data for TARA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is TARA's market cap?

TARA (Protara Therapeutics Inc) has a market capitalization of $0.29 billion, making it a small-cap stock.

What is TARA's price to book ratio?

TARA trades at a price-to-book (P/B) ratio of 1.50, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does TARA pay dividends?

TARA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is TARA's dividend yield?

TARA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is TARA stock a good long-term investment?

TARA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is TARA's revenue growth rate?

Revenue growth data for TARA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for TARA are available on our dashboard with complete income statement analysis.

What are the risks of investing in TARA?

Key risks for TARA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does TARA compare to its competitors?

Compare TARA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize TARA's performance and positioning.

What is TARA's stock price target for 2026?

Our AI model provides price targets for TARA based on fundamental analysis: Bull case $7.07 (+30%), Base case $6.26 (+15%), Bear case $4.90 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about TARA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for TARA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is TARA's next earnings report?

TARA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

TARA - Protara Therapeutics Inc

NYSE * Health Care * Biotechnology

$5.44

+$0.31 (+6.04%)

About Protara Therapeutics Inc

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

TARA Key Statistics

Market Cap

$294.22M

P/B Ratio

1.50

EPS

$-1.34

Employees

How TARA Compares to Peers

TARA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
TARA(This stock)	$294.22M	N/A	0%	0.0%	-
AMGNAmgen Inc	$191.53B	24.9	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.2	-0%	0.1%	vs BIIB

Protara Therapeutics Inc Company Information

Headquarters: New York; U.S.A
Website: www.protaratx.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 20, 2026 at 12:55 AM EDT

Ready to invest in TARA?

Commission-free trading available. Affiliate links.

TARA Lician Score

5% confidence

4.0/10

Neutral

TARA has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates TARAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

TARA Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for TARA

Dashboard

Enter a ticker to analyze